<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03256240</url>
  </required_header>
  <id_info>
    <org_study_id>1303013645</org_study_id>
    <nct_id>NCT03256240</nct_id>
  </id_info>
  <brief_title>Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis</brief_title>
  <official_title>Prospective Randomized Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis in the Prevention of Post-operative Recurrence of Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Crohn's and Colitis Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study proposes a randomized prospective study comparing the Kono-S anastomosis to the&#xD;
      standard side-to-side anastomosis.This will be a multi-center randomized prospective trial.&#xD;
      Patients with Crohn's ileitis or Crohn's ileocolitis requiring resection will be randomized&#xD;
      to undergo either the Kono-S anastomosis or the side-to-side functional end anastomosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Aim:&#xD;
&#xD;
        -  The primary aim of this study is to compare the post-operative recurrence of CD using&#xD;
           the Rutgeerts score at 3-6 months between the novel Kono-S anastomosis (Group1) and&#xD;
           side-to-side functional end anastomosis (Group2).&#xD;
&#xD;
        -  The secondary aim is to evaluate the post-operative recurrence of CD using the Rutgeerts&#xD;
           score at 12-18 months, surgical recurrence rate at 60 months between the groups.&#xD;
&#xD;
      Methods&#xD;
&#xD;
      Design: This will be a multi-center randomized prospective trial. Patients with Crohn's&#xD;
      ileitis or Crohn's ileocolitis requiring initial resection will be randomized to undergo&#xD;
      either the Kono-S anastomosis or the side-to-side functional end anastomosis.&#xD;
&#xD;
      Patients will be randomized into two Groups:&#xD;
&#xD;
      Group 1: Kono-S anastomosis vs. Group 2: side-to-side functional end anastomosis.&#xD;
&#xD;
      The purpose of this study is to compare the post-operative recurrence of Crohn's disease&#xD;
      between Kono-S procedure and the side-to-side functional end anastomosis. In any intestine&#xD;
      surgery, after the sick portion of the bowel is removed, the intestinal tract is restored by&#xD;
      reconnecting the healthy ends together. The new connecting line is called anastomosis, and&#xD;
      could be created in a variety ways by the surgeon. This study will compare two different&#xD;
      intestinal connections called Kono-S anastomosis and the traditional side-to-side functional&#xD;
      end anastomosis. Initial studies have demonstrated that the Kono-S anastomosis has prevented&#xD;
      endoscopic evidence of the post-operative recurrence of Crohn's disease at greater rates than&#xD;
      the traditional side-to-side functional end anastomosis.&#xD;
&#xD;
      Follow up: Patients will be discharged on no prophylactic treatments and they will be&#xD;
      followed post- operatively at 3 to 6 and 12 to 18 months with a colonoscopy to assess for&#xD;
      endoscopic recurrence. The mucosa will be graded with the Rutgeerts score for post-operative&#xD;
      recurrence. All colonoscopies are part of the standard treatment. All patients will have also&#xD;
      standard 30 days follow up, 3 to 6 months, 12 months, and up to 60 months follow up.&#xD;
&#xD;
      Follow up Care: Patients with a Rutgeerts score at 3 months of:&#xD;
&#xD;
        -  0, 1 or 2a will be followed prospectively without introducing medical treatment.&#xD;
&#xD;
        -  above &gt;2a will initiate medical therapy for Crohn's disease&#xD;
&#xD;
        -  should the patient's symptoms warrant colonoscopic evaluation earlier than three months;&#xD;
           this will be done at the gastroenterologist's discretion. This is a standard of care&#xD;
&#xD;
      Colonoscopic images (still color photos acceptable) will be shown to a gastroenterologist&#xD;
      blinded to the goal of the study for determination of the Rutgeerts score.&#xD;
&#xD;
      Harvey Bradshaw Index as a marker of clinical disease activity will be used. This will be&#xD;
      recorded before procedure (baseline), 3 to 6 and 12-18 months, and at 60 months post&#xD;
      procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2014</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to undergo either the Kono-S anastomosis or the side-to-side functional end anastomosis.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative remission of Crohn's disease between 3 and 6 months after surgery</measure>
    <time_frame>3-6 months after surgery</time_frame>
    <description>Endoscopic remission with a Rutgeert score between 3 and 6 months in order to determine if the Kono-S procedure is more likely to prevent post-operative recurrence of Crohn's disease compared with the side-to-side functional end anastomosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative remission of Crohn's disease between 12 and 18 months after surgery</measure>
    <time_frame>12-18 months after surgery</time_frame>
    <description>Endoscopic remission with a Rutgeert score at 12 to 18 months in order to determine if the Kono-S procedure is more likely to prevent post-operative recurrence of Crohn's disease compared with the side-to-side functional end anastomosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with surgical recurrence at 60 months</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinical disease activity measured by Harvey Bradshaw Index</measure>
    <time_frame>up to 60 months</time_frame>
    <description>Harvey Bradshaw Index is a marker of clinical disease activity</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>side-to-side functional end anastomosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>side-to-side functional end anastomosis creation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kono-S</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>antimesenteric functional side-to-side handsewn anastomosis, known as the Kono-S anastomosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>side-to-side functional end anastomosis</intervention_name>
    <description>type of anastomosis</description>
    <arm_group_label>side-to-side functional end anastomosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Kono-S analstomosis</intervention_name>
    <description>antimesenteric anastomosis</description>
    <arm_group_label>Kono-S</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with Crohn's ileitis or ileocolitis requiring initial surgical resection.&#xD;
&#xD;
          2. Age of 18 years and older, male and female&#xD;
&#xD;
          3. All Phenotypes of Crohn's diisease will be included: nonpenetrating (B1), stricturing&#xD;
             (B2), and penetrating (fistulating) (B3), according to the Vienna classification&#xD;
&#xD;
          4. The patients can be on any medications coming into surgery, including prior anti-&#xD;
             tumor necrosis factor(TNF) therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients under 18 years of age&#xD;
&#xD;
          2. Patients with recurrent Crohn's&#xD;
&#xD;
          3. Pregnant patients&#xD;
&#xD;
          4. Patients with more than one non-contiguous site of active disease, thus requiring&#xD;
             multiple resections or additional bowel sparing procedures at the time of surgery.&#xD;
&#xD;
          5. Patients with Crohn's disease extending to the cecum and ascending colon&#xD;
&#xD;
          6. Patients who will need preventive postoperative medical treatment&#xD;
&#xD;
          7. Patients that need change of surgical procedure as per the surgeon at the time of the&#xD;
             intraoperative abdominal evaluation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrizio Michelassi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Koiana Trencheva, BSN,M.S.</last_name>
    <phone>646-962-2342</phone>
    <email>kivanova@med.cornell.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koiana Ivanova Trencheva, BSN,M.S.</last_name>
      <phone>646-962-2342</phone>
      <email>kivanova@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katerina Wells, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Katalin Martits-Chalangari, MD</last_name>
      <email>KATALIN.MARTITSCHALANGARI@BSWHealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>University Clinics Gasthuisberg Herestraat</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Terrasson</last_name>
      <phone>+32 16 34 08 37</phone>
      <email>isabelle.terrasson@uzleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Andre D' Hoore, MD</last_name>
      <phone>+32 16 34 08 37</phone>
      <email>andre.dhoore@uzleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Andre D' Hoore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gisele Aaltonen, MD, PhD</last_name>
      <email>gisele.aaltonen@helsinki.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Theresien Hospital and St. Hedwigs Clinic gGmbH</name>
      <address>
        <city>Mannheim</city>
        <zip>68165</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Kienle,, MD</last_name>
      <phone>0049621 / 424-4252,</phone>
      <email>p.kienle@theresienkrankenhaus.de</email>
    </contact>
    <contact_backup>
      <last_name>Kirsten Staiger</last_name>
      <phone>(0621) 424-5809</phone>
      <email>K.Staiger@theresienkrankenhaus.de</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Kienle,, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Humanitas University Hospital</name>
      <address>
        <city>Rozzano</city>
        <state>Milan</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annalisa Maroli, PhD</last_name>
      <phone>39 02 82247776</phone>
      <email>annalisa.maroli@cancercenter.humanitas.it</email>
    </contact>
    <contact_backup>
      <last_name>Antonino Spinelli, MD</last_name>
      <phone>39 02 82247776</phone>
      <email>antonino.spinelli@hunimed.eu</email>
    </contact_backup>
    <investigator>
      <last_name>Antonino Spinelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico University Hospital</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaetano Luglio, MD</last_name>
      <email>gaetano.luglio@unina.it</email>
    </contact>
    <contact_backup>
      <last_name>Francesca Tropeano</last_name>
      <email>fpt.tropeano@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kono T, Ashida T, Ebisawa Y, Chisato N, Okamoto K, Katsuno H, Maeda K, Fujiya M, Kohgo Y, Furukawa H. A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease. Dis Colon Rectum. 2011 May;54(5):586-92. doi: 10.1007/DCR.0b013e318208b90f.</citation>
    <PMID>21471760</PMID>
  </reference>
  <reference>
    <citation>Kono T, Fichera A. Kono-S anastomosis for Crohn's disease: narrative - a video vignette. Colorectal Dis. 2014 Oct;16(10):833. doi: 10.1111/codi.12722.</citation>
    <PMID>25040294</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 5, 2014</study_first_submitted>
  <study_first_submitted_qc>August 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2017</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Crohn's recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

